成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> Expert Opinion on Drug Safety >>article
Expert Opinion on Drug Safety

Expert Opinion on Drug Safety

IF: 3
Download PDF

The use and safety of doxycycline hyclate and other second-generation tetracyclines.

Published:1 September 2008 DOI: 10.1517/14740338.7.5.571 PMID: 18759709
Barry Sloan, Noah Scheinfeld

Abstract

Tetracyclines have long been used to treat a wide variety of medical conditions, especially in the field of dermatology. Unfortunately, safety concerns, especially gastrointestinal (GI), have always been present. Other safety concerns have included tooth development in children, candidiasis, vestibular concerns, photosensitivity/phototoxicity, and more unusual adverse effects such as uncontrolled hypertension. This article first discusses the pharmacological development of the tetracyclines from the first to the second generation versions with an emphasis on the safety concerns, especially with regards to doxycycline hyclate (DH). Second, the adverse effects of the tetracyclines are discussed. Third, the favorable side effect profile of DH delayed release capsules (Doryx) is compared with DH powder contained in tablets (Vibramycin). Fourth, the increased use with a continued favorable safety profile is also discussed concerning the subantimicrobial dosing of DH for acne. Fifth, the safety of periodontic uses of DH is discussed. Last, the favorable safety profiles of the 2006 approved uses of an anti-inflammatory dose of 40 mg doxycycline for rosacea and an extended-release minocycline tablet for acne are also discussed.

Substances (3)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Doxycycline hyclate 24390-14-5 C24H31ClN2O9 611 suppliers $17.47-$1650.00
Doxycycline 564-25-0 C22H24N2O8 336 suppliers Inquiry
Minocycline 10118-90-8 C23H27N3O7 180 suppliers $15.00-$790.00

Similar articles

IF:1.7

Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies.

European Heart Journal Supplements Brian Olshansky,?Mina K Chung,etc Published: 6 October 2020
IF:1.3

Pharmacokinetics after administration of an injectable experimental long-acting parenteral formulation of doxycycline hyclate in goats.

American journal of veterinary research Dinorah Vargas, Lilia Gutierrez,etc Published: 1 August 2008